FRANKLIN RESOURCES INC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 38777 San Mateo, CA

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$28,652,923

+$6,596,351 QoQ

Shares Held

845,718

+15.5% QoQ

Ownership

0.073%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#90

of 675 holders

Holding Since

Sep 2020

13 quarters on record

Voting authority Sole 63% Shared 0% None 37%

Healthcare · as of Jun 30, 2026

FRANKLIN RESOURCES INC holds $845,206,958 across 34 Drug Manufacturers - Specialty & Generic names. TEVA ranks #10 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	340,275	$184,371,197
2	INDV	Indivior Pharmaceuticals, Inc.	3,316,358	$136,070,166
3	NBIX	Neurocrine Biosciences Inc	553,068	$93,214,076
4	VTRS	Viatris Inc	5,658,439	$89,856,006
5	ZTS	Zoetis Inc.	912,367	$65,562,688
6	ALKS	Alkermes plc.	1,170,242	$61,320,679
7	AMLX	Amylyx Pharmaceuticals, Inc.	2,950,225	$52,986,040
8	RDY	Dr Reddys Laboratories Ltd	2,844,583	$41,218,006

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,652,923	845,718	+15.5%	Shares	Defined	2026-08-13
2026-03-31	$22,056,572	732,290	+4172.4%	Shares	Defined	2026-05-13
2025-12-31	$534,937	17,140	+0.4%	Shares	Defined	2026-02-11
2025-09-30	$344,914	17,075	+12.2%	Shares	Defined	2025-11-13
2025-06-30	$255,169	15,225	-67.5%	Shares	Defined	2025-08-12
2024-12-31	$1,032,044	46,826	-69.8%	Shares	Defined	2025-02-12
2024-09-30	$2,794,739	155,091	+141.7%	Shares	Defined	2024-11-27
2024-06-30	$1,042,778	64,171	+422.2%	Shares	Defined	2024-08-14
2021-09-30	$119,694	12,289	-38.5%	Shares	Defined	2021-11-12
2021-06-30	$197,802	19,980	+37.9%	Shares	Defined	2021-08-13
2021-03-31	$167,249	14,493	-91.8%	Shares	Defined	2021-05-13
2020-12-31	$1,704,904	176,674	+1174.0%	Shares	Defined	2021-02-10
2020-09-30	$124,950	13,868	—	Shares	Defined	2020-11-12
No filing history on record for this holder in this stock.